ArchiMed invests in PlasmidFactory, a German gene and cell therapy specialist
ArchiMed invests in PlasmidFactory
PlasmidFactory is the second investment of ArchiMed’s MED Platform II, which began fundraising in January.
ArchiMed invests in PlasmidFactory
PlasmidFactory is the second investment of ArchiMed’s MED Platform II, which began fundraising in January.